Locations:
Search
New evidence supports ART, but caveats remain
Study shows risk of overtreating patients
Investigating cell-free nucleic acids for cancer detection
Hypoxic induction of vasorin regulates Notch1 turnover
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Accurate risk prediction reduces costs and false positives
Final results of PERSIST-2 confirm benefit; PAC203 enrolling
An oncologist weighs in
The first approved treatment for men with nonmetastatic castration-resistant prostate cancer (M0CRPC)
Rigid formulas do docs a disservice
A rare form of sarcoma treated by cytoreductive surgery
Advertisement
Advertisement